The initial orders will support genedrive’s international distribution partners in promotion and in-country evaluation activities in their respective countries, to provide more extensive access to this life-changing test.
James Cheek, Chief Executive Officer of genedrive plc, said: “We are delighted to see the first orders come in from those countries we have signed distribution agreements with. We look forward to the continued expansion of our international sales throughout 2024 as we drive forward with our sales and marketing strategies and deliver value to our shareholders.”
